These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22570100)

  • 1. [Pluripotent stem cells for cell replacement therapy of diabetes].
    Naujok O; Lenzen S
    Dtsch Med Wochenschr; 2012 May; 137(20):1062-6. PubMed ID: 22570100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pluripotent stem cells, a potential source of beta-cells for diabetes therapy.
    Hansson M; Madsen OD
    Curr Opin Investig Drugs; 2010 Apr; 11(4):417-25. PubMed ID: 20336589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Making β cells from adult tissues.
    Efrat S; Russ HA
    Trends Endocrinol Metab; 2012 Jun; 23(6):278-85. PubMed ID: 22537825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differentiation of pluripotent stem cells into pancreatic lineages].
    Mfopou JK; Bouwens L
    Med Sci (Paris); 2013; 29(8-9):736-43. PubMed ID: 24005628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research status and prospect of stem cells in the treatment of diabetes mellitus.
    Liu X; Wang Y; Li Y; Pei X
    Sci China Life Sci; 2013 Apr; 56(4):306-12. PubMed ID: 23564185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cells and nuclear reprogramming.
    Saric T; Hescheler J
    Minim Invasive Ther Allied Technol; 2008; 17(2):64-78. PubMed ID: 18465442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regenerative medicine: using liver to generate pancreas for treating diabetes.
    Meivar-Levy I; Ferber S
    Isr Med Assoc J; 2006 Jun; 8(6):430-4. PubMed ID: 16833177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
    Romano G
    Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of human-induced pluripotent stem cells.
    Park IH; Lerou PH; Zhao R; Huo H; Daley GQ
    Nat Protoc; 2008; 3(7):1180-6. PubMed ID: 18600223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise review: Epidermal grafting: the case for pluripotent stem cells.
    Lemaître G; Nissan X; Baldeschi C; Peschanski M
    Stem Cells; 2011 Jun; 29(6):895-9. PubMed ID: 21472820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult reserve stem cells and their potential for tissue engineering.
    Young HE; Duplaa C; Romero-Ramos M; Chesselet MF; Vourc'h P; Yost MJ; Ericson K; Terracio L; Asahara T; Masuda H; Tamura-Ninomiya S; Detmer K; Bray RA; Steele TA; Hixson D; el-Kalay M; Tobin BW; Russ RD; Horst MN; Floyd JA; Henson NL; Hawkins KC; Groom J; Parikh A; Blake L; Bland LJ; Thompson AJ; Kirincich A; Moreau C; Hudson J; Bowyer FP; Lin TJ; Black AC
    Cell Biochem Biophys; 2004; 40(1):1-80. PubMed ID: 14983110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An overview of pluripotent stem cell lines].
    Kieffer E; Kuntz S; Viville S
    Med Sci (Paris); 2010 Oct; 26(10):848-54. PubMed ID: 20929676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The advantages of hair follicle pluripotent stem cells over embryonic stem cells and induced pluripotent stem cells for regenerative medicine.
    Amoh Y; Katsuoka K; Hoffman RM
    J Dermatol Sci; 2010 Dec; 60(3):131-7. PubMed ID: 21036545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Induced pluripotent stem cells generated from reprogramming differentiated cells by defined factors].
    Xia X; Chu J; Chen X
    Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1121-7. PubMed ID: 18837383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of human insulin-producing cells for cell therapy of diabetes.
    Russ HA; Efrat S
    Pediatr Endocrinol Rev; 2011 Dec; 9(2):590-7. PubMed ID: 22397143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of isogenic pluripotent stem cells.
    Byrne JA
    Hum Mol Genet; 2008 Apr; 17(R1):R37-41. PubMed ID: 18632695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cells and promises of neuroregenerative medicine.
    Verma A; Verma N
    Neurol India; 2011; 59(4):555-7. PubMed ID: 21891933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Origins of pluripotent stem cells.
    Roelen BA; Chuva De Sousa Lopes SM
    Minerva Ginecol; 2011 Aug; 63(4):351-63. PubMed ID: 21747344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human hair follicle pluripotent stem (hfPS) cells promote regeneration of peripheral-nerve injury: an advantageous alternative to ES and iPS cells.
    Amoh Y; Kanoh M; Niiyama S; Hamada Y; Kawahara K; Sato Y; Hoffman RM; Katsuoka K
    J Cell Biochem; 2009 Aug; 107(5):1016-20. PubMed ID: 19507228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of retinal cells from mouse and human induced pluripotent stem cells.
    Hirami Y; Osakada F; Takahashi K; Okita K; Yamanaka S; Ikeda H; Yoshimura N; Takahashi M
    Neurosci Lett; 2009 Jul; 458(3):126-31. PubMed ID: 19379795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.